• About us
• Contact

Advertisement

Organisation › Details

Catalent Biologics, Madison biological manufacturing facility

Opened in April 2013 and recently expanded, Catalent Biologics’ Madison site provides development, manufacturing and analytical services for new biological entities and biosimilars. The facility was designed for flexible cGMP production from 10 liter up to 4,000 liter scale, and nonGMP production up to 250 liter scale and makes extensive use of single-use technologies and unidirectional flow to maximize safety and efficiency. Manufacturing is supported by integrated analytical, process and formulation development capabilities and separate microbiology and quality control functions. *

 

	Start	2013-04-01 start
	Group	Catalent (Group)
	Industry	contract manufacturing (biologicals)
	Industry 2	GPEx® technology
	Region	Madison, WI
	Country	United States (USA)
	City	n. a. Madison, WI
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«: Valerius Biopharma AG. (5/14/18). "Press Release: Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars". Somerset, NJ & Basel.
		Record changed: 2023-07-10

Advertisement

More documents for Catalent (Group)

• [1] Catalent, Inc.. (4/6/22). "Press Release: Catalent Acquires Facility in Oxfordshire to Expand Biologics Capabilities in the UK and Across Europe". Somers, NJ....
• [2] Catalent. (6/24/21). "Press Release: Catalent to Acquire RheinCell Therapeutics, Strengthening a Path Towards Industrialization of Induced Pluripotent Stem Cell-based Therapies". Somerset, NJ....
• [3] T-Knife GmbH. (9/21/20). "Press Release: T-Knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy". Berlin & Somerset, NJ....
• [4] Catalent, Inc.. (2/3/20). "Press Release: Catalent, Inc. Announces Pricing of Public Offering of Common Stock". Somers, NJ....
• [5] Aldevron LLC. (5/15/18). "Press Release: Aldevron Names Marc Wolff Chief Financial Officer"....
• [6] Valerius Biopharma AG. (5/14/18). "Press Release: Catalent Biologics and Valerius Biopharma to Collaborate on Manufacture of Specialty Biosimilars". Somerset, NJ & Basel....
• [7] CRISPR Therapeutics AG. (11/8/17). "Press Release: CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update". Zug & Cambridge, MA....
• [8] CRISPR Therapeutics AG. (6/6/17). "Press Release: CRISPR Therapeutics and MaSTherCell SA Sign Service Agreement for the Development and Manufacturing of Allogeneic Cell Therapies". Basel, Cambridge, MA & Gosselies....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.